drugset / Trial / NCT00881140

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

NCT00881140

Phase 2 Completed 30 enrolled BioPro Medical Ltd
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of daily dosage of vaginally mifepristone on reduction of uterine fibroids size and the symptoms associated with uterine fibroids.

Timeline

Start
2009-04
Primary completion
2012-05
Completion
2012-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 10 mg Other